Doseology Sciences Inc.
Doseology Sciences Inc. (DOSEF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
dosef · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Doseology Sciences Inc.You DOSEF | $1M | N/A | — | — |
 Core One Labs Inc. CLABF | $0M | N/A | — | -$0.49 |
 Captiva Verde Wellness Corp. CPIVF | $8M | N/A | — | -$0.00 |
 Ensysce Biosciences, Inc. ENSC | $2M | N/A | — | -$3.98 |
 Enzon Pharmaceuticals, Inc. ENZN | $4M | N/A | — | -$4.59 |
 Futura Medical plc FAMDF | $1M | N/A | — | -$0.03 |
 Evolutionary Genomics, Inc. FNAM | $0M | N/A | — | -$0.30 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Doseology Sciences Inc. (DOSEF) measures how much investors pay for each dollar of the company's trailing earnings. DOSEF's current PE ratio of N/A is calculated by dividing its stock price of $0.13 by its TTM earnings per share of —.
Frequently asked questions
DOSEF pe ratio · 6 questionsDOSEF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.13 and TTM EPS of —. Data sourced from Financial Modeling Prep via DOSEF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Doseology Sciences Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09